Heart failure, older people and frailty Diagnosis of heart failure and frailty can often be masked by other long-term conditions, making the delivery of treatment goals complicated.…
Vitamin D not protective against cardiovascular events Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.…
Majority of Welsh community pharmacists have never submitted a Yellow Card report, study finds More than half of community pharmacists in Wales have never submitted a Yellow Card report, according to survey results published in Pharmacoepidemiology and Drug Safety.…
MMR: the struggle for national coverage Introduction of a measles vaccine in 1968 has reduced annual cases in England from around 460,000 to less than 1,000. However, the levels of vaccine coverage needed to eradicate measles remain elusive.…
Warnings on ‘diet’ drug must go further, RPS says The Royal Pharmaceutical Society has welcomed moves to highlight the potential lethal risks of the fertiliser 2,4 dinitrophenol that is used in some diet pills, but says they do not go far enough and reiterated its call for it to be banned.…
Stevens–Johnson syndrome and toxic epidermal necrolysis Practical guidelines for the treatment and management of Stevens–Johnson syndrome and toxic epidermal necrolysis, rare but life-threatening conditions that are normally caused by drugs or infections.…
Study finds gender differences in reporting adverse drug reactions Women are more likely to report adverse drug reactions to certain drugs than men, research published in the British Journal of Clinical Pharmacology has shown.…
Aspirin increases bleeding risk in patients receiving warfarin Compared with patients taking warfarin monotherapy, those taking aspirin and warfarin were at a higher risk of a bleeding event but the rate of thrombotic events was similar.…
Comprehensive guide to identifying diseases caused by drug therapy Drug-induced Diseases: Prevention, Detection, and Management, edited by James E Tisdale and Douglas A Miller.…
Oral preparations of HRT increase risk of VTE, study finds Most oral preparations of hormone replacement therapy (HRT) are associated with a higher risk of venous thromboembolism (VTE), a study published in The BMJ has found.…
